Close Menu

NEW YORK – Progenity announced on Tuesday that it has entered a definitive securities purchase agreement for the sale of approximately $25 million in units comprising the company's common stock and warrants to purchase additional stock.

The deal is with two unnamed healthcare investment-focused funds.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.